We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.49B
AUM Growth
-$96.8M
(-1.1%)
Cap. Flow
-$229M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
17.82%
Holding
2,013
New
45
Increased
399
Reduced
1,471
Closed
95
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$32.4M |
| 2 |
Amgen
AMGN
|
+$13.1M |
| 3 |
Medtronic
MDT
|
+$8.19M |
| 4 |
CELG
Celgene Corp
CELG
|
+$8.07M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.03M |
Top Sells
| 1 |
Visa
V
|
+$36.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$14.1M |
| 3 |
Microsoft
MSFT
|
+$10.4M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$9.41M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$8.96M |
Sector Composition
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.97% |
| 3 | Financials | 14.32% |
| 4 | Communication Services | 7.87% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.9T
| $411M | 4.84% |
13,219,640
-69,272
| -0.5% | -$2.09M |
|
|
2
Microsoft
MSFT
$2.93T
| $186M | 2.2% |
4,586,785
-237,953
| -5% | -$10.4M |
|
3
Alphabet (Google) Class C
GOOG
$4.22T
| $180M | 2.12% |
6,562,047
-265,787
| -4% | -$7.12M |
|
4
Gilead Sciences
GILD
$167B
| $124M | 1.46% |
1,266,331
+69,466
| +6% | +$7.05M |
|
5
ExxonMobil
XOM
$611B
| $115M | 1.35% |
1,350,938
+40,750
| +3% | +$3.61M |
|
|
6
Amgen
AMGN
$198B
| $112M | 1.32% |
702,840
+83,434
| +13% | +$13.1M |
|
7
Biogen
BIIB
$30.4B
| $100M | 1.18% |
237,045
-1,979
| -0.8% | -$780K |
|
8
Meta Platforms (Facebook)
META
$1.64T
| $98.7M | 1.16% |
1,199,922
-48,284
| -4% | -$3.78M |
|
9
Intel
INTC
$478B
| $92.8M | 1.09% |
2,967,053
-248,620
| -8% | -$8.39M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $91.6M | 1.08% |
794,882
+67,562
| +9% | +$8.07M |
|
11
Johnson & Johnson
JNJ
$609B
| $86.5M | 1.02% |
859,841
-14,385
| -2% | -$1.46M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.06T
| $84.6M | 1% |
585,913
-52,650
| -8% | -$7.75M |
|
13
Amazon
AMZN
$2.66T
| $83M | 0.98% |
4,461,340
-189,980
| -4% | -$3.34M |
|
14
JPMorgan Chase
JPM
$907B
| $82.1M | 0.97% |
1,356,004
-122,406
| -8% | -$7.25M |
|
15
Wells Fargo
WFC
$265B
| $82M | 0.97% |
1,506,926
-145,486
| -9% | -$7.86M |
|
16
Cisco
CSCO
$441B
| $80.1M | 0.94% |
2,909,536
-138,315
| -5% | -$3.89M |
|
17
Chevron
CVX
$373B
| $78.6M | 0.93% |
748,839
+39,740
| +6% | +$4.24M |
|
18
Comcast
CMCSA
$85B
| $64.8M | 0.76% |
2,295,610
-132,950
| -5% | -$3.82M |
|
19
Qualcomm
QCOM
$181B
| $61.2M | 0.72% |
882,349
-53,861
| -6% | -$3.8M |
|
20
Procter & Gamble
PG
$349B
| $59.7M | 0.7% |
727,989
-11,577
| -2% | -$995K |
|
|
WBA
21
DELISTED
Walgreens Boots Alliance
WBA
| $58M | 0.68% |
685,522
+406,956
| +146% | +$32.4M |
|
22
Regeneron Pharmaceuticals
REGN
$70.9B
| $58M | 0.68% |
128,438
+15,623
| +14% | +$6.62M |
|
23
3M
MMM
$83.4B
| $54.5M | 0.64% |
395,499
-3,960
| -1% | -$546K |
|
24
Goldman Sachs
GS
$314B
| $52.6M | 0.62% |
279,710
-19,668
| -7% | -$3.66M |
|
25
Bank of America
BAC
$430B
| $51.9M | 0.61% |
3,370,185
-342,120
| -9% | -$5.49M |
|
Similar funds
ProShare Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, ProShare Advisors held 2,013 positions worth $8.49B, down 1.1% from $8.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors's Q1 2015 filing shows 45 new, 399 increased, 1,471 reduced and 95 closed positions. Its largest new stake was Qorvo: 60,564 shares worth $4.83M. The largest sale was Visa, an estimated $36.5M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- ProShare Advisors's largest Q1 2015 buy was Qorvo: 60,564 shares worth $4.83M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q1 2015, an estimated $32.4M increase.
- ProShare Advisors's biggest Q1 2015 reduction was Visa, cutting an estimated $36.5M.
- ProShare Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $14.1M.
- ProShare Advisors's ten largest holdings make up 18% of its $8.49B portfolio in Q1 2015.
- ProShare Advisors opened 45 new positions and closed 95 in Q1 2015.
- ProShare Advisors's portfolio value fell 1.1% quarter-over-quarter to $8.49B.
Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.